Scipher Medicine, a leader in precision medicine for autoimmune diseases, and Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence, announced a strategic partnership to accelerate precision medicine and expand the Immunology Multimodal Network, advancing shared decision making for patients with rheumatoid arthritis (RA). This collaboration will leverage Scipher’s unique data and intelligence derived from its PrismRA® precision medicine diagnostic and expand the Atropos Evidence™ Network , enhancing the immunology multimodal network on Atropos Health’s GENEVA OS™(Generative Evidence Acceleration Operating System).
“By combining Scipher’s unique RA data assets with Atropos Health’s cutting-edge AI evidence generation tools, like ChatRWD, we can provide clinicians with powerful tools to make more informed treatment decisions and deliver personalized care.”
HealthTech Insights: Blueprint Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Scipher’s PrismRA test identifies patients who are unlikely to respond to specific RA therapies, enabling personalized treatment decisions. By integrating this data into the Atropos Evidence Network, clinicians utilizing Atropos Health’s evidence generating solutions such as Green Button and ChatRWD™, healthcare’s first AI-powered chat to database application, delivering real-world evidence in minutes, will have the opportunity to generate evidence from the immunology multimodal network for shared decision making.
“This partnership brings together the power of precision medicine and real-world evidence to improve patient outcomes in rheumatoid arthritis,” said Reg Seeto, CEO, Scipher Medicine. “By combining Scipher’s unique RA data assets with Atropos Health’s cutting-edge AI evidence generation tools, like ChatRWD, we can provide clinicians with powerful tools to make more informed treatment decisions and deliver personalized care.”
HealthTech Insights: Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
“Demand for additional data sets from clinicians and researchers continues to grow, and expanding the Atropos Evidence Network, the largest federated data network in healthcare with over 300M patient records, with Scipher Medicine will further meet this demand,” said Dr. Brigham Hyde, co-founder and CEO of Atropos Health. “Scipher’s PrismRA data will ultimately lead to more opportunities to generate rapid evidence with ChatRWD™ and more rapidly close the evidence gap in medicine.”
This collaboration marks a significant step towards advancing precision medicine in rheumatology and improving the lives of patients with RA.
HealthTech Insights: Rectangle Health Partners with LOYALLT to Offer Custom In-House Dental Membership Plans
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – businesswire
